https://nova.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Analysis of Fat1 cadherin and identification of novel biomarkers for acute leukemia https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:14447 Wed 15 May 2019 09:58:18 AEST ]]> Shutting the gate: targeting endocytosis in acute leukemia https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:39597 Wed 15 Jun 2022 12:54:03 AEST ]]> A Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:36614 Thu 28 Oct 2021 12:37:17 AEDT ]]> Fetal growth and risk of childhood acute lymphoblastic leukemia: results from an Australian case-control study https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:7623 Sat 24 Mar 2018 08:34:43 AEDT ]]> Exposure to house painting and the use of floor treatments and the risk of childhood acute lymphoblastic leukemia https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:12564 Sat 24 Mar 2018 08:18:24 AEDT ]]> Exposure to professional pest control treatments and the risk of childhood acute lymphoblastic leukemia https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:13263 Sat 24 Mar 2018 08:15:58 AEDT ]]> Parental alcohol consumption and risk of childhood acute lymphoblastic leukemia and brain tumors https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:17308 Sat 24 Mar 2018 08:01:48 AEDT ]]> Paternal intake of folate and vitamins B6 and B12 before conception and risk of childhood acute lymphoblastic leukemia https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:19855 Sat 24 Mar 2018 07:57:05 AEDT ]]> FAT1 Gene Expression in Iranian Acute Lymphoid and Myeloid Leukemia Patients https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51247 0.2). Nonetheless, the mean expression level of FAT1 was significantly higher in leukemic patients (AML and ALL) than in normal CD34+ cells (p=0.029). Additionally, the FAT1 expression levels were significantly higher in both CD34+ and CD34-leukemic patients than in normal CD34+ cells (p=0.028). Conclusion: No significant differences were found between FAT1 expression in CD34+ and CD34-leukemic samples (p> 0.3). Thus, higher FAT1 expression was evident in ALL and AML leukemia cells but this appeared unrelated to CD34 expression. This suggests in a proportion of adult acute leukemia, FAT1 expression may prove to be a suitable target for therapeutic strategies.]]> Mon 28 Aug 2023 12:28:18 AEST ]]> Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLG https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:54830 Fri 15 Mar 2024 11:53:47 AEDT ]]> A multi-center randomized controlled trial to reduce unmet needs, depression, and anxiety among hematological cancer patients and their support persons https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38253 Fri 03 Sep 2021 14:46:19 AEST ]]>